Piramal Pharma Share Price Target (2026 - 2050)
Piramal Pharma Share Price Target 2026 2027 2028 2029 2030 2035 2040 2045 2050 accurate price prediction with target calculator, just enter ur expected cagr and it will show you target
Navigate to Section you Like
Piramal Pharma Share Price Statistic
The Piramal Pharma Share Price Statistics section summarizes the stock's key historical performance metrics, including the current share price, daily, weekly, monthly, yearly, and long-term returns. It also highlights the best and worst calendar years, average annual return, maximum drawdown, and the number of positive years. These statistics provide a quick snapshot of Piramal Pharma's historical performance and help investors understand its long-term return profile and market volatility.
CURRENT PRICE
1 DAY
1 WEEK
1 MONTH
6 MONTHS
1 YEAR
3 YEARS
5 YEARS
BEST YEAR
WORST YEAR
AVERAGE YEAR
POSITIVE YEARS
Piramal Pharma Target and CAGR Calculator
The Piramal Pharma Target Calculator helps you to calculate future share price Piramal Pharma CAGR Calculator calculates historical annualized returns over different investment periods. Together, these tools help investors compare past performance with future expectations.So you can be realistic about future price.
Piramal Pharma Target Price Calculator
The Piramal Pharma Target Price Calculator estimates the future share price based on your expected annual return (CAGR) and investment period. Simply choose a target year and expected growth rate to calculate the projected share price, expected return, and total gain. Just enter your Target Year and Expected Returns, and get target instantly.
Target Price
₹0.00
0 years
0%
₹0
Piramal Pharma CAGR Calculator
Use the Piramal Pharma CAGR Calculator to calculate the compound annual growth rate (CAGR) for any investment period. You can check historical CAGR for the last 1, 2, 3, 5, 10, 15, 20, 25, and 30 years, or select any available period to understand the company's long-term performance. This helps investors compare returns across different investment horizons and evaluate long-term wealth creation.
Just Select no of years you want to check cagr
Piramal Pharma Charts
The Piramal Pharma Charts provides interactive historical charts, including the price chart, drawdown chart, yearly return chart, and monthly return chart. Analyze long-term trends, compare performance across different periods, identify major corrections, and understand the stock's historical volatility using multiple time ranges from 1 month to the maximum available data.
Scanner & Screeners
Piramal Pharma Historical Returns & Price History
Check out Piramal Pharma's historical returns and daily price history in one place. The historical returns table shows monthly and yearly percentage returns, It will make you easy to identify strong and weak periods, seasonal trends, and long-term performance. You can check which month Piramal Pharma stock is performing well and which it is not. The historical price data table provides daily Open, High, Low, and Close (OHLC) prices, allowing investors to analyze past price movements and compare historical trading activity.
Piramal Pharma Performance
The Piramal Pharma Historical Returns table displays monthly and yearly returns for each calendar year. It helps you to understand how the stock has performed across different market cycles.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yearly |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Loading... | |||||||||||||
Piramal Pharma Price History
The Piramal Pharma Historical Price Data table provides daily Open, High, Low, and Close (OHLC) prices. Use the year and month filters to view historical trading data
| Date | Open (₹) | High (₹) | Low (₹) | Close (₹) |
|---|---|---|---|---|
| Loading data... | ||||
Piramal Pharma Share Price Target Tomorrow
| Targets | Stoploss | |
|---|---|---|
| 1 | ₹218.38 | ₹210.94 |
| 2 | ₹223.09 | ₹208.21 |
| 3 | ₹225.82 | ₹203.50 |
The 1st target for Piramal Pharma Tomorrow is ₹218.38, 2nd target is ₹223.09, and 3rd target is ₹225.82. For risk management, the 1st stoploss is at ₹210.94 and the 2nd (wider) stoploss is at ₹208.21.
Piramal Pharma Share Price Target Next Week
| Targets | Stoploss | |
|---|---|---|
| 1 | ₹222.65 | ₹202.39 |
| 2 | ₹231.64 | ₹191.12 |
| 3 | ₹242.91 | ₹182.13 |
The 1st target for Piramal Pharma Next Week is ₹222.65, 2nd target is ₹231.64, and 3rd target is ₹242.91. For risk management, the 1st stoploss is at ₹202.39 and the 2nd (wider) stoploss is at ₹191.12.
Piramal Pharma Share Price Target Next Month
| Targets | Stoploss | |
|---|---|---|
| 1 | ₹209.88 | ₹173.73 |
| 2 | ₹224.14 | ₹151.84 |
| 3 | ₹246.03 | ₹137.58 |
The 1st target for Piramal Pharma Next Month is ₹209.88, 2nd target is ₹224.14, and 3rd target is ₹246.03. For risk management, the 1st stoploss is at ₹173.73 and the 2nd (wider) stoploss is at ₹151.84.
PIRAMAL PHARMA Share Price Target 2026
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 6% | ₹207.35 | ₹172.14 |
| 2 | 19% | ₹232.78 | ₹162.36 |
| 3 | 24% | ₹242.56 | - |
* Targets calculated based on the latest available price as of 2026-07-31.
The 1st target for Piramal Pharma in 2026 is ₹211.26 (8% CAGR), 2nd target is ₹223.00 (14% CAGR), and 3rd target is ₹244.51 (25% CAGR). For risk management, the 1st stoploss is at ₹185.83 and the 2nd (wider) stoploss is at ₹168.22.
PIRAMAL PHARMA Share Price Target 2027
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 7% | ₹228.63 | ₹202.99 |
| 2 | 18% | ₹252.13 | ₹183.76 |
| 3 | 24% | ₹264.95 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target for Piramal Pharma in 2027 is ₹228.63 (7% CAGR), 2nd target is ₹252.13 (18% CAGR), and 3rd target is ₹264.95 (24% CAGR). For risk management, the 1st stoploss is at ₹202.99 and the 2nd (wider) stoploss is at ₹183.76.
PIRAMAL PHARMA Share Price Target 2028
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 7% | ₹244.63 | ₹202.99 |
| 2 | 18% | ₹297.51 | ₹183.76 |
| 3 | 24% | ₹328.54 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target for Piramal Pharma in 2028 is ₹244.63 (7% CAGR), 2nd target is ₹297.51 (18% CAGR), and 3rd target is ₹328.54 (24% CAGR). For risk management, the 1st stoploss is at ₹202.99 and the 2nd (wider) stoploss is at ₹183.76.
PIRAMAL PHARMA Share Price Target 2029
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 7% | ₹261.75 | ₹202.99 |
| 2 | 18% | ₹351.07 | ₹183.76 |
| 3 | 24% | ₹407.39 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target for Piramal Pharma in 2029 is ₹261.75 (7% CAGR), 2nd target is ₹351.07 (18% CAGR), and 3rd target is ₹407.39 (24% CAGR). For risk management, the 1st stoploss is at ₹202.99 and the 2nd (wider) stoploss is at ₹183.76.
PIRAMAL PHARMA Share Price Target 2030
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 7% | ₹280.08 | ₹202.99 |
| 2 | 18% | ₹414.26 | ₹183.76 |
| 3 | 24% | ₹505.16 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target for Piramal Pharma in 2030 is ₹280.08 (7% CAGR), 2nd target is ₹414.26 (18% CAGR), and 3rd target is ₹505.16 (24% CAGR). For risk management, the 1st stoploss is at ₹202.99 and the 2nd (wider) stoploss is at ₹183.76.
PIRAMAL PHARMA Share Price Target 2035
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 7% | ₹392.82 | ₹202.99 |
| 2 | 18% | ₹947.72 | ₹183.76 |
| 3 | 24% | ₹1,480.94 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target for Piramal Pharma in 2035 is ₹392.82 (7% CAGR), 2nd target is ₹947.72 (18% CAGR), and 3rd target is ₹1,480.94 (24% CAGR). For risk management, the 1st stoploss is at ₹202.99 and the 2nd (wider) stoploss is at ₹183.76.
PIRAMAL PHARMA Share Price Target 2040
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 7% | ₹550.96 | ₹202.99 |
| 2 | 18% | ₹2,168.16 | ₹183.76 |
| 3 | 24% | ₹4,341.57 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target for Piramal Pharma in 2040 is ₹550.96 (7% CAGR), 2nd target is ₹2,168.16 (18% CAGR), and 3rd target is ₹4,341.57 (24% CAGR). For risk management, the 1st stoploss is at ₹202.99 and the 2nd (wider) stoploss is at ₹183.76.
PIRAMAL PHARMA Share Price Target 2045
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 7% | ₹772.74 | ₹202.99 |
| 2 | 18% | ₹4,960.23 | ₹183.76 |
| 3 | 24% | ₹12,727.87 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target for Piramal Pharma in 2045 is ₹772.74 (7% CAGR), 2nd target is ₹4,960.23 (18% CAGR), and 3rd target is ₹12,727.87 (24% CAGR). For risk management, the 1st stoploss is at ₹202.99 and the 2nd (wider) stoploss is at ₹183.76.
PIRAMAL PHARMA Share Price Target 2050
| CAGR | Target | Stoploss | |
|---|---|---|---|
| 1 | 7% | ₹1,083.81 | ₹202.99 |
| 2 | 18% | ₹11,347.80 | ₹183.76 |
| 3 | 24% | ₹37,313.33 | - |
* Targets are projected using historical CAGR and market assumptions.
The 1st target for Piramal Pharma in 2050 is ₹1,083.81 (7% CAGR), 2nd target is ₹11,347.80 (18% CAGR), and 3rd target is ₹37,313.33 (24% CAGR). For risk management, the 1st stoploss is at ₹202.99 and the 2nd (wider) stoploss is at ₹183.76.
Piramal Pharma Share Price Prediction 2026 - 2050
Piramal Pharma Share Price forecast from 2026 to 2050. Here you will find the target and stoploss levels based on historical performance, CAGR projections, and market analysis. You can also use CAGR calculator to find out target as per your desired CAGR returns.
| Year | T1 (7%) | T2 (18%) | T3 (24%) | SL 1 (5%) | SL 2 (14%) | SL 3 (%) |
|---|---|---|---|---|---|---|
| 2026 | ₹232.90 | ₹245.72 | ₹260.68 | ₹194.44 | ₹175.21 | - |
| 2027 | ₹228.63 | ₹252.13 | ₹264.95 | ₹202.99 | ₹183.76 | - |
| 2028 | ₹244.63 | ₹297.51 | ₹328.54 | ₹202.99 | ₹183.76 | - |
| 2029 | ₹261.75 | ₹351.07 | ₹407.39 | ₹202.99 | ₹183.76 | - |
| 2030 | ₹280.08 | ₹414.26 | ₹505.16 | ₹202.99 | ₹183.76 | - |
| 2035 | ₹392.82 | ₹947.72 | ₹1,480.94 | ₹202.99 | ₹183.76 | - |
| 2040 | ₹550.96 | ₹2,168.16 | ₹4,341.57 | ₹202.99 | ₹183.76 | - |
| 2045 | ₹772.74 | ₹4,960.23 | ₹12,727.87 | ₹202.99 | ₹183.76 | - |
| 2050 | ₹1,083.81 | ₹11,347.80 | ₹37,313.33 | ₹202.99 | ₹183.76 | - |
Market Research
Piramal Pharma Share News Today | Latest News | Price Target Analysis
Piramal Pharma Share Price Target 2026 to 2050
Piramal Pharma
Piramal Pharma is a pharmaceutical company that makes medicines, healthcare products, and active pharmaceutical ingredients (APIs). It serves both domestic and international markets.
The company focuses on areas like critical care, consumer healthcare, and contract manufacturing. Piramal Pharma is known for innovation and global partnerships.
By supporting affordable healthcare, Piramal Pharma plays an important role in India’s pharma industry.
Top 5 Key Takeaways: Piramal Pharma (PPLPHARMA) Share Price Performance
- Current Valuation: Trading at ₹213.67 (Healthcare sector) as of 2026-08-21. Today's movement is -2.99 (-1.38%).
- Short-Term Returns: 1-Day: -1.38% | 1-Week: +3.40% | 1-Month: +15.62%.
-
Long-Term Returns: 6-Month: +33.10% | 1-Year: +11.26% | 3-Year: +113.88% | 5-Year: +
Deprecated: number_format(): Passing null to parameter #1 ($num) of type float is deprecated in /home/ttopback/public_html/share-price-target/piramal-pharma-share-price-target.php on line 1259
0.00%. - Best vs. Worst Year: Peak return in 2024 (+92.17%); lowest return in 2022 (-34.49%).
- Historical Consistency: Average annual return of +12.70% over 5 years, yielding positive returns in 3/5 years.
Frequently asked questions on Piramal Pharma Share Price
Yes Piramal Pharma is a public sector company, it is partially owned by govt of India.
Piramal Pharma is now a 100% Debt free company.
Piramal Pharma is a good stock to invest for long term, however you may well keep this in mind that psu stocks some times underperform overall market for several years. if you have patience to hold then only you can invest for long term or invest with a time based or price based stop loss
In covid crash the Piramal Pharma share price fell as low as Rs.20 from it all time high
Yes, Piramal Pharma stock is highly liquid, which allows to enter and exit quickly.
No. A investor or trader should never invest all his capital in a single share, however he must create a portfolio of stocks
Data sourced from NSE and BSE public records, calculated using adjusted closing prices.
